ArticleClinical and translational radiation oncology2023

Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial.

Amar U Kishan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.